{"version":"1.0","type":"link","title":"Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan.","author_name":"Morimoto K 외","author_url":"https://prs-insight.online/author/Morimoto%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/121967","thumbnail_width":1200,"thumbnail_height":630}